Vidipha Central Pharmaceutical JSC (HOSE:VDP)

Market Cap	1.06T +36.9%
Revenue (ttm)	950.89B +1.8%
Net Income	63.81B -11.2%
EPS	2,889.37
Shares Out	22.08M
PE Ratio	16.58
Forward PE	n/a
Dividend	1,500.00 (3.13%)
Ex-Dividend Date	Mar 19, 2025

Volume	708
Average Volume	1,245
Open	46,500
Previous Close	48,000
Day's Range	46,500 - 47,900
52-Week Range	33,000 - 58,000
Beta	0.10
RSI	48.07
Earnings Date	Mar 26, 2026

About HOSE:VDP

Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products under the Vidipha brand. It offers analgesics, antipyretics, gastrointestinal agents, antidiabetic agents, antibiotics, antivirals, antifungals, antihistamines, anti-allergic agents, respiratory agents, cardiovascular, neurological, antihypertensive agents, diuretics, vitamin, minerals, antiseptics, and others. The company also engages in hotel and real estate business; and provision of drug storage and testing, and technology transfer consulting servi...

• Industry: Pharmaceutical Preparations
• Founded: 2003
• Employees: 195
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: VDP

Financial Performance

In 2025, HOSE:VDP's revenue was 950.89 billion, an increase of 1.76% compared to the previous year's 934.49 billion. Earnings were 63.81 billion, a decrease of -11.16%.